La Comisión Federal para la Protección Contra Riesgos Sanitarios (Cofepris) informó este lunes a través de un comunicado que autorizó el uso de emergencia de los primeros tres lotes de la vacuna CanSino Biologics, envasada en Querétaro por la farmacéutica Drugmex.
Asimismo, dio a conocer que dichos lotes, producidos en China y envasados en México, se encontraban en proceso de análisis por la Comisión de Control Analítico y Ampliación de Cobertura (CCAyAC), desde el 5 de marzo del 2021.
| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
